Risankizumab-rzaa
Showing 1 - 25 of 60
Psoriasis Trial in New York (Risankizumab-Rzaa, Punch biopsies of the skin at baseline visit, Punch biopsies of the skin at week
Recruiting
- Psoriasis
- Risankizumab-Rzaa
- +2 more
-
New York, New YorkThe Rockefeller Univesity
Jun 9, 2022
Crohn's Disease Trial (Risankizumab SC, Placebo for risankizumab)
Not yet recruiting
- Crohn's Disease
- Risankizumab SC
- Placebo for risankizumab
- (no location specified)
Sep 26, 2023
Assess Participant-Reported Real-World Experience of
Recruiting
- Crohn's Disease
-
London, London, City Of, United KingdomGuys and St Thomas NHS Foundation Trust /ID# 258986
Nov 7, 2023
Disease Activity and Adverse Events In Adult Moderate to Severe
Recruiting
- Crohn's Disease
-
Calgary, Alberta, Canada
- +48 more
Apr 24, 2023
Psoriasis Vulgaris Trial in Belgium (Venapuncture, Patient questionnaires)
Recruiting
- Psoriasis Vulgaris
- Venapuncture
- Patient questionnaires
-
Ghent, East-Flanders, Belgium
- +6 more
Jan 5, 2023
Healthy Volunteers Trial in United States (Risankizumab Dose A, Risankizumab Dose B)
Active, not recruiting
- Healthy Volunteers
- Risankizumab Dose A
- Risankizumab Dose B
-
Anaheim, California
- +4 more
Jan 12, 2023
Genital Psoriasis, Scalp Psoriasis Trial (Risankizumab, Placebo for Risankizumab)
Not yet recruiting
- Genital Psoriasis
- Scalp Psoriasis
- Risankizumab
- Placebo for Risankizumab
- (no location specified)
Jul 24, 2023
Juvenile Psoriatic Arthritis Trial (Adalimumab, Risankizumab)
Not yet recruiting
- Juvenile Psoriatic Arthritis
- (no location specified)
Oct 20, 2023
Ulcerative Colitis (UC) Trial in Worldwide (risankizumab IV, for risankizumab, risankizumab SC)
Recruiting
- Ulcerative Colitis (UC)
- risankizumab IV
- +2 more
-
Coronado, California
- +429 more
Aug 11, 2022
Ulcerative Colitis (UC) Trial in Worldwide (risankizumab, for risankizumab)
Enrolling by invitation
- Ulcerative Colitis (UC)
- risankizumab
- placebo for risankizumab
-
Coronado, California
- +423 more
May 26, 2022
Disease Symptoms in Adult Moderate to Severe Psoriasis Treated
Recruiting
- Psoriasis
-
Beer Sheva, HaDarom, Israel
- +7 more
Aug 3, 2022
Disease State When Subcutaneous Risankizumab Injection is Given
Recruiting
- Psoriasis
-
Taichung City, Taiwan
- +1 more
May 19, 2022
Ulcerative Colitis (UC), Crohn's Disease Trial in Germany, Israel, United States (Risankizumab, Cytochrome P450 (CYP)
Completed
- Ulcerative Colitis (UC)
- Crohn's Disease
- Risankizumab
- Cytochrome P450 (CYP) Substrates
-
Coronado, California
- +5 more
Oct 20, 2022
Arthritis, Psoriatic, Healthy Trial in Graz (Guselkumab, Risankizumab)
Terminated
- Arthritis, Psoriatic
- Healthy
-
Graz, AustriaMedical University Graz
Jul 22, 2022
Palmoplantar Pustulosis (PPP) Trial in Japan (Risankizumab, Placebo)
Active, not recruiting
- Palmoplantar Pustulosis (PPP)
- Risankizumab
- Placebo
-
Ichinomiya-shi, Aichi, Japan
- +38 more
Mar 1, 2022
Patients With Moderate to Severe Chronic Plaque Psoriasis
Active, not recruiting
- Chronic Plaque Psoriasis
-
Lomas de Zamora, Buenos Aires, Argentina
- +277 more
Nov 24, 2021
Psoriasis Trial in Portland (risankizumab)
Active, not recruiting
- Psoriasis
-
Portland, OregonOregon Medical Research Center
Aug 15, 2022
Psoriasis Trial in Worldwide (Risankizumab, Placebo for Risankizumab)
Active, not recruiting
- Psoriasis
- Risankizumab
- Placebo for Risankizumab
-
Glendale, Arizona
- +54 more
Mar 2, 2022